Technology

Bionano Genomics

$8.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.71 (+8.42%) Today
-$0.98 (-10.72%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BNGO and other stocks, options, and ETFs commission-free!

About BNGO

Bionano Genomics, Inc. Common Stock, also called Bionano Genomics, is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA. The listed name for BNGO is Bionano Genomics, Inc. Common Stock.

CEO
Robert Erik Holmlin
Employees
97
Headquarters
San Diego, California
Founded
2003
Market Cap
1.14B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
243.69M
High Today
$9.95
Low Today
$8.93
Open Price
$9.30
Volume
138.33M
52 Week High
$9.95
52 Week Low
$0.25

Collections

BNGO News

MarketWatch9h

Bionano Genomics to sell more shares, stock falls

Bionano Genomics Inc. BNGO, +8.42% on Tuesday announced its second share sale in less than a month amid an unexplained spike in its price and volume, sending sh

BNGO Earnings

-$0.71
-$0.47
-$0.24
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

NOVSW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure